Mark E. Graham

214 Hawkesbury Road
Westmead, NSW 2145, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms.

Pharmaceutical Engineering of Lipid-Based Nanocarriers for Cancer Nanomedicines: From Doxorubicin to mRNA Platforms.

Journal: ACS biomaterials science & engineering

Published: July 14, 2026

Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.

Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2026

Anti-inflammatory and phosphorylation effects of CFTR modulator triple therapy in cystic fibrosis.

Anti-inflammatory and phosphorylation effects of CFTR modulator triple therapy in cystic fibrosis.

Journal: iScience

Published: April 23, 2026

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3.

Journal: Acta neuropathologica

Published: March 29, 2026

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 04, 2026

Pyroxd1 is essential for murine viability with the homozygous N155S recurrent variant linked to myopathy, muscle hypotrophy and osteopenia.

Pyroxd1 is essential for murine viability with the homozygous N155S recurrent variant linked to myopathy, muscle hypotrophy and osteopenia.

Journal: Acta neuropathologica communications

Published: November 10, 2025

Medicinal cannabis plant extract (NTI164) modifies epigenetic, ribosomal, and immune pathways in paediatric acute-onset neuropsychiatric syndrome.

Medicinal cannabis plant extract (NTI164) modifies epigenetic, ribosomal, and immune pathways in paediatric acute-onset neuropsychiatric syndrome.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: November 06, 2025

Cumulative environmental exposures adversely impact social behaviour and are associated with dysregulation of genes and proteins involved in epigenetic, ribosomal, and immune regulation in male mice.

Cumulative environmental exposures adversely impact social behaviour and are associated with dysregulation of genes and proteins involved in epigenetic, ribosomal, and immune regulation in male mice.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: July 27, 2025

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Cross-tissue immune profiling of APOE ε4 reveals early dysregulation in Alzheimer's disease.

Journal: Research square

Published: July 25, 2025

Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome.

Epigenetic, ribosomal, and immune dysregulation in paediatric acute-onset neuropsychiatric syndrome.

Journal: Molecular psychiatry

Published: June 28, 2024

Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome.

Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome.

Journal: EBioMedicine

Published: January 10, 2024

Trans-omic profiling uncovers molecular controls of early human cerebral organoid formation.

Trans-omic profiling uncovers molecular controls of early human cerebral organoid formation.

Journal: Cell reports

Published: January 03, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026